Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy.
作者信息
Vestergaard Christian, Deleuran Mette
机构信息
Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Department of Dermatology, Aarhus University Hospital, Aarhus, DK, Denmark.
出版信息
J Eur Acad Dermatol Venereol. 2025 Sep;39(9):1527-1528. doi: 10.1111/jdv.20832.
Abstract
摘要
相似文献
1
Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy.
J Eur Acad Dermatol Venereol. 2025 Sep;39(9):1527-1528. doi: 10.1111/jdv.20832.
2
Maternal, Fetal, and Labour Outcomes of Dupilumab Use for Atopic Dermatitis During Pregnancy: A Systematic Review.
J Cutan Med Surg. 2025 Jan-Feb;29(1):51-55. doi: 10.1177/12034754241290806. Epub 2024 Oct 20.
3
Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment.
Adv Ther. 2025 May 19. doi: 10.1007/s12325-025-03209-4.
4
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.
5
Changes in skin barrier integrity by electrical impedance spectroscopy during dupilumab treatment on a child with severe atopic dermatitis.
Turk J Pediatr. 2024 Nov 16;66(5):637-642. doi: 10.24953/turkjpediatr.2024.4902.
6
Ocular surface evaluation in atopic dermatitis patients on dupilumab: A prospective observational study.
J Fr Ophtalmol. 2025 Jun;48(6):104544. doi: 10.1016/j.jfo.2025.104544. Epub 2025 May 8.
7
Utility of the Atopic Dermatitis Control Tool for Assessing Long-term Control of Atopic Dermatitis in Korean Patients on Dupilumab.
Allergy Asthma Immunol Res. 2025 Jul;17(4):519-526. doi: 10.4168/aair.2025.17.4.519.
8
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.
Dermatol Ther (Heidelb). 2025 Jun 2. doi: 10.1007/s13555-025-01443-w.
9
High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis.
Front Immunol. 2023 Apr 20;14:1160710. doi: 10.3389/fimmu.2023.1160710. eCollection 2023.
10
The association between expression of CD200 on B lymphocytes and the count of eosinophils and basophils in atopic dermatitis patients with and without dupilumab therapy - Pilot study.
Int Immunopharmacol. 2024 May 10;132:112023. doi: 10.1016/j.intimp.2024.112023. Epub 2024 Apr 10.
本文引用的文献
1
Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity-matched cohort study.
J Eur Acad Dermatol Venereol. 2025 Sep;39(9):1576-1587. doi: 10.1111/jdv.20670. Epub 2025 Apr 2.
2
Dupilumab use for atopic dermatitis during pregnancy: A systematic review.
J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e750-e755. doi: 10.1111/jdv.20570. Epub 2025 Feb 4.
3
Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe.
J Eur Acad Dermatol Venereol. 2024 Jan;38(1):31-41. doi: 10.1111/jdv.19512. Epub 2023 Oct 11.
4
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period.
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1644-1659. doi: 10.1111/jdv.15709. Epub 2019 Jun 23.
5
Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.
J Am Acad Dermatol. 2016 Oct;75(4):681-687.e11. doi: 10.1016/j.jaad.2016.05.028. Epub 2016 Aug 17.
Zotero 插件